https://journal.chestnet.org/article/S0012-3692(12)60129-9/pdf

Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Prospective Cohort Study

https://www.healthcare.uiowa.edu/familymedicine/fpinfo/Docs/Chest%20Rx%20VTE%20Feb%202016.pdf

Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report

It is important that the medical profession plays a significant role in critically evaluating the use of diagnostic procedures and therapies as they are introduced and tested in the detection, management, or prevention of disease states. Rigorous and expert analysis of the available data documenting absolute and relative benefits and risks of those procedures and therapies can produce helpful guidelines that improve the effectiveness of care, optimize patient outcomes, and favorably affect the overall cost of care by focusing resources on the most effective strategies.

The American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA) have jointly engaged in the production of such guidelines in the area of cardiovascular disease since 1980. The ACC/AHA Task Force on Practice Guidelines, whose charge is to develop, update, or revise practice guidelines for important cardiovascular diseases and procedures, directs this effort. The Task Force is pleased to have this guideline developed in conjunction with the European Society of Cardiology (ESC). Writing committees are charged with the task of performing an assessment of the evidence and acting as an independent group of authors to develop or update written recommendations for clinical practice.

Experts in the subject under consideration have been selected from all 3 organizations to examine subject-specific data and write guidelines. The process includes additional representatives from other medical practitioner and specialty groups when appropriate. Writing committees are specifically charged to perform a formal literature review, weigh the strength of evidence for or against a particular treatment or procedure, and include estimates of expected health outcomes where data exist. Patient-specific modifiers, comorbidities, and issues of patient preference that might influence the choice of particular tests or therapies are considered as well as frequency of follow-up and cost effectiveness. When available, information from studies on cost will be considered; however, review …

/pdf/acc-aha-esc-2006-guidelines-for-management-of-patients-with-5a3f1emfzy.pdf

ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

On the mechanisms of biocompatibility.

Prosthetic femorocrural bypass surgery and adjuvant arteriovenous fistulae.

INTRODUCTION: Vascular access (VA) surgery, a prerequisite for hemodialysis treatment of end-stage renal-disease (ESRD) patients, is hampered by complication rates, which are frequently related to flow enhancement. To assist in VA surgery planning, a patient-specific computer model for postoperative flow enhancement was developed. The purpose of this study is to assess the benefit of non contrast-enhanced magnetic resonance angiography (NCE-MRA) data as patient-specific geometrical input for the model-based prediction of surgery outcome. METHODS: 25 ESRD patients were included in this study. All patients received a NCE-MRA examination of the upper extremity blood vessels in addition to routine ultrasound (US). Local arterial radii were assessed from NCE-MRA and converted to model input using a linear fit per artery. Venous radii were determined with US. The effect of radius measurement uncertainty on model predictions was accounted for by performing Monte-Carlo simulations. The resulting flow prediction interval of the computer model was compared with the postoperative flow obtained from US. Patients with no overlap between model-based prediction and postoperative measurement were further analyzed to determine whether an increase in geometrical detail improved computer model prediction. RESULTS: Overlap between postoperative flows and model-based predictions was obtained for 71% of patients. Detailed inspection of non-overlapping cases revealed that the geometrical details that could be assessed from NCE-MRA explained most of the differences, and moreover, upon addition of these details in the computer model the flow predictions improved. CONCLUSIONS: The results demonstrate clearly that NCE-MRA does provide valuable geometrical information for VA surgery planning. Therefore, it is recommended to use this modality, at least for patients at risk for local or global narrowing of the blood vessels as well as for patients for whom an US-based model prediction would not overlap with surgical choice, as the geometrical details are crucial for obtaining accurate flow predictions.

https://pure.tue.nl/ws/files/3843636/36860050639254.pdf

The benefit of non contrast-enhanced magnetic resonance angiography for predicting vascular access surgery outcome: a computer model perspective.

PurposeA disfunctioning peritoneal dialysis (PD) catheter has been reported in upto 35%. We report different salvage techniques used and its outcome.MethodsWe retrospectively reviewed our database ...

Revision techniques for failed PD catheters: outcome in a University Hospital

20. Gonzalez-Cuadrado S, Lopez-Armada MJ, Gomez-Guerrero C 28. Mitra D, Jaffe EA, Weksler B, Hajjar KA, Soderland C, Laurence J. Thrombotic thrombocytopenic purpura and sporet al. Anti-Fas antibodies induce cytolysis and apoptosis in cultured human mesangial cells. Kidney Int 1996; 49: 1064–1070 adic hemolytic–uremic syndrome plasmas induce apoptosis in restricted lineages of human microvascular endothelial cells. 21. Schelling JR, Nkemere N, Kopp JB, Cleveland RP. Fasdependent fratricidal apoptosis is a mechanism of tubular epitheBlood 1997; 89: 1224–1234 29. Wada T, Schwarting A, Kinoshita K et al. Fas on renal lial cell deletion in chronic renal failure. Lab Invest 1998; 78: 813–824 parenchymal cells does not promote autoimmune nephritis in MRL mice. Kidney Int 1999; 55: 841–851 22. Healy E, Dempsey M, Lally C, Ryan MP. Apoptosis and necrosis: mechanisms of cell death induced by cyclosporine A 30. Mooney A, Jobson T, Bacon R, Kitamura M, Savill J. Cytokines promote glomerular mesangial cell survival in vitro by stimulusin a renal proximal tubular cell line. Kidney Int 1998; 54: 1955–1966 dependent inhibition of apoptosis. J Immunol 1997; 159: 3949–3960 23. Akasaka Y, Ishikawa Y, Kato S et al. Induction of Fas-mediated apoptosis in a human renal epithelial cell line by interferon31. Swenson KM, Ke B, Wang T et al. Fas ligand gene transfer to renal allografts in rats: effects on allograft survival. gamma: involvement of Fas-mediated apoptosis in acute renal rejection. Mod Pathol 1998; 11: 1107–1114 Transplantation 1998; 65: 155–160 32. Vaux DL. Immunology. Ways around rejection. Nature 1998; 24. Conaldi PG, Biancone L, Bottelli A et al. HIV-1 kills renal tubular epithelial cells in vitro by triggering an apoptotic pathway 394: 133 33. Kimura M, Ogata Y, Shimada K et al. Nephritogenicity of the involving caspase activation and fas upregulation. J Clin Invest 1998; 102: 2041–2049 lprcg gene on the MRL background. Immunology 1992; 76: 498–504 25. Nogae S, Miyazaki M, Kobayashi N et al. Induction of apoptosis in ischemia–reperfusion model of mouse kidney: possible 34. Drappa J, Vaishnaw AK, Sullivan KE, Chu JL, Elkon KB. Fas gene mutations in the Canale–Smith syndrome, an inherited involvement of Fas. J Am Soc Nephrol 1998; 9: 620–631 26. Hattori T, Shindo S, Kawamura H. Apoptosis and expression lymphoproliferative disorder associated with autoimmunity. N Engl J Med 1996; 335: 1643–1649 of Bax protein and Fas antigen in glomeruli of a remnantkidney model. Nephron 1998; 79: 186–191 35. Fleck M, Kern ER, Zhou T et al. Apoptosis mediated by fas but not tumor necrosis factor receptor 1 prevents chronic disease 27. Takemura T, Murakami K, Miyazato H, Yagi K, Yoshioka K. Expression of Fas antigen and Bcl-2 in human glomeruloin mice infected with murine cytomegalovirus. J Clin Invest 1998; 102: 1431–1443 nephritis. Kidney Int 1995; 48: 1886–1892

Antithrombotic measures for indwelling intravenous haemodialysis catheters—Columbus' egg yet to be found

BackgroundVascular access is the lifeline for end-stage renal disease patients needing hemodialysis treatment. For dialysis treatment two needles are placed into the vascular access. Few studies on...

Jan H.M. Tordoir

Papers

Prosthetic femorocrural bypass surgery and adjuvant arteriovenous fistulae.

The benefit of non contrast-enhanced magnetic resonance angiography for predicting vascular access surgery outcome: a computer model perspective.

Revision techniques for failed PD catheters: outcome in a University Hospital

Antithrombotic measures for indwelling intravenous haemodialysis catheters—Columbus' egg yet to be found

Dialysis needle hemodynamics in arterio-venous fistulae: a technical report.